T46 — ICD-10-CM Diagnosis Codes

T46 Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
T46.0 Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
T46.0X Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
T46.0X1 Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
T46.0X1A Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter billable
T46.0X1D Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter billable
T46.0X1S Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela billable
T46.0X2 Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
T46.0X2A Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter billable
T46.0X2D Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter billable
T46.0X2S Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela billable
T46.0X3 Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
T46.0X3A Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter billable
T46.0X3D Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter billable
T46.0X3S Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela billable
T46.0X4 Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
T46.0X4A Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter billable
T46.0X4D Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter billable
T46.0X4S Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela billable
T46.0X5 Adverse effect of cardiac-stimulant glycosides and drugs of similar action
T46.0X5A Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter billable
T46.0X5D Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter billable
T46.0X5S Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela billable
T46.0X6 Underdosing of cardiac-stimulant glycosides and drugs of similar action
T46.0X6A Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter billable
T46.0X6D Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter billable
T46.0X6S Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela billable
T46.1 Poisoning by, adverse effect of and underdosing of calcium-channel blockers
T46.1X Poisoning by, adverse effect of and underdosing of calcium-channel blockers
T46.1X1 Poisoning by calcium-channel blockers, accidental (unintentional)
T46.1X1A Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter billable
T46.1X1D Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter billable
T46.1X1S Poisoning by calcium-channel blockers, accidental (unintentional), sequela billable
T46.1X2 Poisoning by calcium-channel blockers, intentional self-harm
T46.1X2A Poisoning by calcium-channel blockers, intentional self-harm, initial encounter billable
T46.1X2D Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter billable
T46.1X2S Poisoning by calcium-channel blockers, intentional self-harm, sequela billable
T46.1X3 Poisoning by calcium-channel blockers, assault
T46.1X3A Poisoning by calcium-channel blockers, assault, initial encounter billable
T46.1X3D Poisoning by calcium-channel blockers, assault, subsequent encounter billable
T46.1X3S Poisoning by calcium-channel blockers, assault, sequela billable
T46.1X4 Poisoning by calcium-channel blockers, undetermined
T46.1X4A Poisoning by calcium-channel blockers, undetermined, initial encounter billable
T46.1X4D Poisoning by calcium-channel blockers, undetermined, subsequent encounter billable
T46.1X4S Poisoning by calcium-channel blockers, undetermined, sequela billable
T46.1X5 Adverse effect of calcium-channel blockers
T46.1X5A Adverse effect of calcium-channel blockers, initial encounter billable
T46.1X5D Adverse effect of calcium-channel blockers, subsequent encounter billable
T46.1X5S Adverse effect of calcium-channel blockers, sequela billable
T46.1X6 Underdosing of calcium-channel blockers
T46.1X6A Underdosing of calcium-channel blockers, initial encounter billable
T46.1X6D Underdosing of calcium-channel blockers, subsequent encounter billable
T46.1X6S Underdosing of calcium-channel blockers, sequela billable
T46.2 Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
T46.2X Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
T46.2X1 Poisoning by other antidysrhythmic drugs, accidental (unintentional)
T46.2X1A Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter billable
T46.2X1D Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter billable
T46.2X1S Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela billable
T46.2X2 Poisoning by other antidysrhythmic drugs, intentional self-harm
T46.2X2A Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter billable
T46.2X2D Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter billable
T46.2X2S Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela billable
T46.2X3 Poisoning by other antidysrhythmic drugs, assault
T46.2X3A Poisoning by other antidysrhythmic drugs, assault, initial encounter billable
T46.2X3D Poisoning by other antidysrhythmic drugs, assault, subsequent encounter billable
T46.2X3S Poisoning by other antidysrhythmic drugs, assault, sequela billable
T46.2X4 Poisoning by other antidysrhythmic drugs, undetermined
T46.2X4A Poisoning by other antidysrhythmic drugs, undetermined, initial encounter billable
T46.2X4D Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter billable
T46.2X4S Poisoning by other antidysrhythmic drugs, undetermined, sequela billable
T46.2X5 Adverse effect of other antidysrhythmic drugs
T46.2X5A Adverse effect of other antidysrhythmic drugs, initial encounter billable
T46.2X5D Adverse effect of other antidysrhythmic drugs, subsequent encounter billable
T46.2X5S Adverse effect of other antidysrhythmic drugs, sequela billable
T46.2X6 Underdosing of other antidysrhythmic drugs
T46.2X6A Underdosing of other antidysrhythmic drugs, initial encounter billable
T46.2X6D Underdosing of other antidysrhythmic drugs, subsequent encounter billable
T46.2X6S Underdosing of other antidysrhythmic drugs, sequela billable
T46.3 Poisoning by, adverse effect of and underdosing of coronary vasodilators
T46.3X Poisoning by, adverse effect of and underdosing of coronary vasodilators
T46.3X1 Poisoning by coronary vasodilators, accidental (unintentional)
T46.3X1A Poisoning by coronary vasodilators, accidental (unintentional), initial encounter billable
T46.3X1D Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter billable
T46.3X1S Poisoning by coronary vasodilators, accidental (unintentional), sequela billable
T46.3X2 Poisoning by coronary vasodilators, intentional self-harm
T46.3X2A Poisoning by coronary vasodilators, intentional self-harm, initial encounter billable
T46.3X2D Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter billable
T46.3X2S Poisoning by coronary vasodilators, intentional self-harm, sequela billable
T46.3X3 Poisoning by coronary vasodilators, assault
T46.3X3A Poisoning by coronary vasodilators, assault, initial encounter billable
T46.3X3D Poisoning by coronary vasodilators, assault, subsequent encounter billable
T46.3X3S Poisoning by coronary vasodilators, assault, sequela billable
T46.3X4 Poisoning by coronary vasodilators, undetermined
T46.3X4A Poisoning by coronary vasodilators, undetermined, initial encounter billable
T46.3X4D Poisoning by coronary vasodilators, undetermined, subsequent encounter billable
T46.3X4S Poisoning by coronary vasodilators, undetermined, sequela billable
T46.3X5 Adverse effect of coronary vasodilators
T46.3X5A Adverse effect of coronary vasodilators, initial encounter billable
T46.3X5D Adverse effect of coronary vasodilators, subsequent encounter billable
T46.3X5S Adverse effect of coronary vasodilators, sequela billable
T46.3X6 Underdosing of coronary vasodilators
T46.3X6A Underdosing of coronary vasodilators, initial encounter billable
T46.3X6D Underdosing of coronary vasodilators, subsequent encounter billable
T46.3X6S Underdosing of coronary vasodilators, sequela billable
T46.4 Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
T46.4X Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
T46.4X1 Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
T46.4X1A Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter billable
T46.4X1D Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter billable
T46.4X1S Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela billable
T46.4X2 Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
T46.4X2A Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter billable
T46.4X2D Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter billable
T46.4X2S Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela billable
T46.4X3 Poisoning by angiotensin-converting-enzyme inhibitors, assault
T46.4X3A Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter billable
T46.4X3D Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter billable
T46.4X3S Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela billable
T46.4X4 Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
T46.4X4A Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter billable
T46.4X4D Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter billable
T46.4X4S Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela billable
T46.4X5 Adverse effect of angiotensin-converting-enzyme inhibitors
T46.4X5A Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter billable
T46.4X5D Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter billable
T46.4X5S Adverse effect of angiotensin-converting-enzyme inhibitors, sequela billable
T46.4X6 Underdosing of angiotensin-converting-enzyme inhibitors
T46.4X6A Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter billable
T46.4X6D Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter billable
T46.4X6S Underdosing of angiotensin-converting-enzyme inhibitors, sequela billable
T46.5 Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
T46.5X Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
T46.5X1 Poisoning by other antihypertensive drugs, accidental (unintentional)
T46.5X1A Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter billable
T46.5X1D Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter billable
T46.5X1S Poisoning by other antihypertensive drugs, accidental (unintentional), sequela billable
T46.5X2 Poisoning by other antihypertensive drugs, intentional self-harm
T46.5X2A Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter billable
T46.5X2D Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter billable
T46.5X2S Poisoning by other antihypertensive drugs, intentional self-harm, sequela billable
T46.5X3 Poisoning by other antihypertensive drugs, assault
T46.5X3A Poisoning by other antihypertensive drugs, assault, initial encounter billable
T46.5X3D Poisoning by other antihypertensive drugs, assault, subsequent encounter billable
T46.5X3S Poisoning by other antihypertensive drugs, assault, sequela billable
T46.5X4 Poisoning by other antihypertensive drugs, undetermined
T46.5X4A Poisoning by other antihypertensive drugs, undetermined, initial encounter billable
T46.5X4D Poisoning by other antihypertensive drugs, undetermined, subsequent encounter billable
T46.5X4S Poisoning by other antihypertensive drugs, undetermined, sequela billable
T46.5X5 Adverse effect of other antihypertensive drugs
T46.5X5A Adverse effect of other antihypertensive drugs, initial encounter billable
T46.5X5D Adverse effect of other antihypertensive drugs, subsequent encounter billable
T46.5X5S Adverse effect of other antihypertensive drugs, sequela billable
T46.5X6 Underdosing of other antihypertensive drugs
T46.5X6A Underdosing of other antihypertensive drugs, initial encounter billable
T46.5X6D Underdosing of other antihypertensive drugs, subsequent encounter billable
T46.5X6S Underdosing of other antihypertensive drugs, sequela billable
T46.6 Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X1 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
T46.6X1A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter billable
T46.6X1D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter billable
T46.6X1S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela billable
T46.6X2 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
T46.6X2A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter billable
T46.6X2D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter billable
T46.6X2S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela billable
T46.6X3 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
T46.6X3A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter billable
T46.6X3D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter billable
T46.6X3S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela billable
T46.6X4 Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
T46.6X4A Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter billable
T46.6X4D Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter billable
T46.6X4S Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela billable
T46.6X5 Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X5A Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter billable
T46.6X5D Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter billable
T46.6X5S Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela billable
T46.6X6 Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X6A Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter billable
T46.6X6D Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter billable
T46.6X6S Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela billable
T46.7 Poisoning by, adverse effect of and underdosing of peripheral vasodilators
T46.7X Poisoning by, adverse effect of and underdosing of peripheral vasodilators
T46.7X1 Poisoning by peripheral vasodilators, accidental (unintentional)
T46.7X1A Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter billable
T46.7X1D Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter billable
T46.7X1S Poisoning by peripheral vasodilators, accidental (unintentional), sequela billable
T46.7X2 Poisoning by peripheral vasodilators, intentional self-harm
T46.7X2A Poisoning by peripheral vasodilators, intentional self-harm, initial encounter billable
T46.7X2D Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter billable
T46.7X2S Poisoning by peripheral vasodilators, intentional self-harm, sequela billable
T46.7X3 Poisoning by peripheral vasodilators, assault
T46.7X3A Poisoning by peripheral vasodilators, assault, initial encounter billable
T46.7X3D Poisoning by peripheral vasodilators, assault, subsequent encounter billable
T46.7X3S Poisoning by peripheral vasodilators, assault, sequela billable
T46.7X4 Poisoning by peripheral vasodilators, undetermined
T46.7X4A Poisoning by peripheral vasodilators, undetermined, initial encounter billable
T46.7X4D Poisoning by peripheral vasodilators, undetermined, subsequent encounter billable
T46.7X4S Poisoning by peripheral vasodilators, undetermined, sequela billable
T46.7X5 Adverse effect of peripheral vasodilators
T46.7X5A Adverse effect of peripheral vasodilators, initial encounter billable
T46.7X5D Adverse effect of peripheral vasodilators, subsequent encounter billable
T46.7X5S Adverse effect of peripheral vasodilators, sequela billable
T46.7X6 Underdosing of peripheral vasodilators
T46.7X6A Underdosing of peripheral vasodilators, initial encounter billable
T46.7X6D Underdosing of peripheral vasodilators, subsequent encounter billable
T46.7X6S Underdosing of peripheral vasodilators, sequela billable
T46.8 Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
T46.8X Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
T46.8X1 Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
T46.8X1A Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter billable
T46.8X1D Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter billable
T46.8X1S Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela billable
T46.8X2 Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
T46.8X2A Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter billable
T46.8X2D Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter billable
T46.8X2S Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela billable
T46.8X3 Poisoning by antivaricose drugs, including sclerosing agents, assault
T46.8X3A Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter billable
T46.8X3D Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter billable
T46.8X3S Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela billable
T46.8X4 Poisoning by antivaricose drugs, including sclerosing agents, undetermined
T46.8X4A Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter billable
T46.8X4D Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter billable
T46.8X4S Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela billable
T46.8X5 Adverse effect of antivaricose drugs, including sclerosing agents
T46.8X5A Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter billable
T46.8X5D Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter billable
T46.8X5S Adverse effect of antivaricose drugs, including sclerosing agents, sequela billable
T46.8X6 Underdosing of antivaricose drugs, including sclerosing agents
T46.8X6A Underdosing of antivaricose drugs, including sclerosing agents, initial encounter billable
T46.8X6D Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter billable
T46.8X6S Underdosing of antivaricose drugs, including sclerosing agents, sequela billable
T46.9 Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
T46.90 Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
T46.901 Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
T46.901A Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter billable
T46.901D Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter billable
T46.901S Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela billable
T46.902 Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
T46.902A Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter billable
T46.902D Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter billable
T46.902S Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela billable
T46.903 Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
T46.903A Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter billable
T46.903D Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter billable
T46.903S Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela billable
T46.904 Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
T46.904A Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter billable
T46.904D Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter billable
T46.904S Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela billable
T46.905 Adverse effect of unspecified agents primarily affecting the cardiovascular system
T46.905A Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter billable
T46.905D Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter billable
T46.905S Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela billable
T46.906 Underdosing of unspecified agents primarily affecting the cardiovascular system
T46.906A Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter billable
T46.906D Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter billable
T46.906S Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela billable
T46.99 Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
T46.991 Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
T46.991A Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter billable
T46.991D Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter billable
T46.991S Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela billable
T46.992 Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
T46.992A Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter billable
T46.992D Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter billable
T46.992S Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela billable
T46.993 Poisoning by other agents primarily affecting the cardiovascular system, assault
T46.993A Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter billable
T46.993D Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter billable
T46.993S Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela billable
T46.994 Poisoning by other agents primarily affecting the cardiovascular system, undetermined
T46.994A Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter billable
T46.994D Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter billable
T46.994S Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela billable
T46.995 Adverse effect of other agents primarily affecting the cardiovascular system
T46.995A Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter billable
T46.995D Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter billable
T46.995S Adverse effect of other agents primarily affecting the cardiovascular system, sequela billable
T46.996 Underdosing of other agents primarily affecting the cardiovascular system
T46.996A Underdosing of other agents primarily affecting the cardiovascular system, initial encounter billable
T46.996D Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter billable
T46.996S Underdosing of other agents primarily affecting the cardiovascular system, sequela billable